🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Gummy(ies) Serving Size
50 Servings
Amino acid/Protein Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Calories
7.4 Calorie(s)
Total Carbohydrates
3.5 Gram(s) (1% DV)
Total Fat
Sodium
3.16 mg (1% DV)
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 250mg

Other Ingredients

Water Isomalt Malitol Citrus Pectin natural Orange flavor Beta-Carotene Adipic Acid Citric Acid Sodium Citrate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take 1 serving (1 gummy) daily or as directed by your healthcare professional. Do not exceed more than 8 gummies within a 24 hour time period.

⚠️ Warnings & Precautions

Warning: Discontinue use and consult a medical doctor immediately if you experience unusual symptoms. Consult a medical doctor before use if you have been treated for or diagnosed with or have a family history of any medical condition, or if you are using any prescription or over the counter drug(s) including blood thinners.

Consult a medical doctor before starting any diet or exercise program. Improper use of this product will not improve results and is not advised. Use only as directed.

🧪 Formulation Notes

Gelatin and Gluten Free

Vegan Friendly

Branch Chain Amino Acids Orange Mist Flavor Natural & Artificial Flavor

Product Details

UPC / SKU 6 12520 51285 9
DSLD Entry Date 2021-06-23
Product Type Amino acid/Protein
Form Gummy or Jelly
Brand Eye Candy
DSLD ID 249635
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →